References
- Jin, Y. H., Lee, S.J., Chung, M. H., Park, J. H., Park, Y. I.,Cho, T. H. and Lee, S. K. : Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism. Arch. Pharm. Res. 22, 232 (1999) https://doi.org/10.1007/BF02976355
- 김동현, Prokidin의 랫드에서 흡수, 분포, 대사 및 배설 연구, 한국과학기술원 생체대사연구센터 (2000)
- Hajdu, J., Adams, G. and Lee, H. K. : Preformulation study of pelrinone hydrochloride. J. Pharm. Sci. 77, 921 (1988) https://doi.org/10.1002/jps.2600771104
- Parasrampuria, J. and Gupta, V. D. : Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.J. Pharm. Sci. 78, 855 (1989)
- Pramar, Y. and Gupta, V. D.: Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability. J. Pharm. Sci. 80, 551 (1991)
- Freeke Hamelijnck, M. A., Stevenson, P. J., Kadaba, P. K. and Damani,L. A : Preformulationdegradation kinetics and chemical stability of a novel triazoline anticonvulsant. J. Pharm. Sci. 81, 392 (1992) https://doi.org/10.1002/jps.2600810421
- Longhi, M. R., de Bertorello, M. M. and Granero, G. E. : Isoxazoles. 8. Preformulation studies of an isoxazolylnaphthoquinone derivative. J. Pharm. Sci, 83, 336 (1994)
- Chun, I. K. and Cho, Y. M. : Influence of pH, temperature, ionic strength and metal ions on the degradation of an iridoid glucoside, aucubin, in buffered aqueous solutions. J. Kor. Pharm. Sci. 25, 239 (1995)
- Kostecka, D., Duncan, M. R. and Wagenknecht, D. : Formulation of a stable parenteral product; clonidine hydrochloride injection. J. Pharm. Sci. Technol, 52, 320 (1998)
- Gwak, H. S. and Chun, I. K.: Preformulationstudy of aspaIatone, a new antithrombotic agent. J. Appl. Pharmacol. 8, 332 (2000)
- Kristl, A. and Vrecer, F : Preformulation investigation of the novel proton pump inhibitor lansoprazole. Drug Dev. Ind. Pharm, 26, 781 (2000)
- Rivera,A B., Hernandez, R. G., Novoa de Armas H., Elizastegi, D. M. and Losada, M. V. : Physico-chemical and solid-state characterization of secnidazole. Farmaco. 55, 700 (2000) https://doi.org/10.1016/S0014-827X(00)00096-3